Ticker > Company >

Alpa Laboratories share price

Alpa Laboratories Ltd.

  56.86 K   105   9 NSE: ALPA BSE: 532878 SECTOR: Pharmaceuticals & Drugs

59.40
+1.80 (3.13%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 59.4

Today's Low

₹ 54.97

52 Week High

₹ 99.75

52 Week Low

₹ 46

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 124.98 Cr.

Enterprise Value

₹ 125.28 Cr.

No. of Shares

2.1 Cr.

P/E

28.59

P/B

0.63

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  93.92

CASH

₹ 1.21 Cr.

DEBT

₹ 1.51 Cr.

Promoter Holding

57.19 %

EPS (TTM)

₹  2.08

Sales Growth

-5.91%

ROE

7.89 %

ROCE

8.9%

Profit Growth

-24.02 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-5.91%
3 Year4.41%
5 Year1.64%

Profit Growth

1 Year-24.02%
3 Year5.81%
5 Year15.53%

ROE%

1 Year7.89%
3 Year10.08%
5 Year10.14%

ROCE %

1 Year8.9%
3 Year12.4%
5 Year12.81%

Debt/Equity

0.0077

Price to Cash Flow

12.56

Interest Cover Ratio

57.949

CFO/PAT (5 Yr. Avg.)

0.568635227858644

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 57.19 0.00
Mar 2026 57.19 0.00
Dec 2025 57.29 0.00
Sep 2025 57.29 0.00
Jun 2025 57.29 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 57.949.
  • Company has a healthy liquidity position with current ratio of 4.0564.
  • The company has a high promoter holding of 57.19%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.91722833895951.

 Limitations

  • The company has shown a poor profit growth of 5.80543500845012% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.41196604877192% for the Past 3 years.
  • Tax rate is low at 10.1403.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 19.11 25.63 29.67 31.4 23.93
Total Expenditure 18.69 28.5 27.54 27.79 27.89
Operating Profit 0.43 -2.87 2.14 3.61 -3.96
Other Income 11.96 3.69 0.26 -0.18 5.83
Interest 0.05 0.05 0.03 0.16 0.11
Depreciation 0.55 0.67 0.65 0.22 0.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 11.78 0.1 1.72 3.05 1.04
Tax 0 0 -0.16 1.69 0
Profit After Tax 11.78 0.1 1.88 1.36 1.04
Adjusted EPS (Rs) 5.6 0.05 0.89 0.65 0.49

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 112.27 92.96 108.74 112.45 105.81
Total Expenditure 101.58 84.88 100.59 107.45 102.51
Operating Profit 10.69 8.08 8.14 5 3.3
Other Income 10.79 9.41 14.87 23.31 15.72
Interest 0.24 0.22 0.39 0.27 0.29
Depreciation 1.66 1.33 1.95 2.2 2.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 19.58 15.93 20.67 25.84 16.64
Tax 5.45 3.31 3.9 6.16 1.69
Net Profit 14.13 12.62 16.78 19.68 14.95
Adjusted EPS (Rs.) 6.71 6 7.97 9.35 7.11

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 21.04 21.04 21.04 21.04 21.04
Total Reserves 110.6 124.07 140.93 161.47 175.54
Borrowings 2.12 0.78 0 0 0
Other N/C liabilities 2.57 2.28 2.4 4.49 3.34
Current liabilities 28.8 29.92 28.06 46.69 51.46
Total Liabilities 165.14 178.09 192.42 233.69 251.38
Assets
Net Block 9.32 7.04 11.47 21.36 20.16
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 17.03 16.82 18.13 18.76 18
Loans & Advances 0.22 1.45 0.52 0.72 0.57
Other N/C Assets 1.76 3.23 2.52 1.4 3.9
Current Assets 136.81 149.55 159.77 191.45 208.75
Total Assets 165.14 178.09 192.42 233.69 251.38
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 19.58 15.72 20.76 25.99 16.64
Adjustment -7.95 -1.47 -9.86 -15.78 -11.19
Changes in Assets & Liabilities -5.85 -0.46 -3.57 12.25 7.34
Tax Paid -3.57 -3.6 -3.63 -4.07 -2.84
Operating Cash Flow 2.2 10.2 3.7 18.39 9.95
Investing Cash Flow -15.61 1.17 -12.45 -12.49 -11.58
Financing Cash Flow 5.41 -3.48 2.26 -5.48 1.16
Net Cash Flow -7.99 7.89 -6.49 0.43 -0.47

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Alpa Laboratories Stock Price Analysis and Quick Research Report. Is Alpa Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Alpa Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Alpa Laboratories has a PE ratio of 27.85023340873 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Alpa Laboratories has ROA of 6.1653% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Alpa Laboratories has a Current ratio of 4.0564.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Alpa Laboratories has a ROE of 7.8889%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Alpa Laboratories has a Debt to Equity ratio of 0.0077 which means that the company has low proportion of debt in its capital.

  • Sales growth: Alpa Laboratories has reported revenue growth of -5.9068% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Alpa Laboratories for the current financial year is 3.12249550135337%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Alpa Laboratories is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Alpa Laboratories is Rs 2.0779. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Alpa Laboratories in Ticker for free. Also, one can get the intrinsic value of Alpa Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Alpa Laboratories FAQs

Q1. What is Alpa Laboratories share price today?
Ans: The current share price of Alpa Laboratories is Rs 57.87.

Q2. What is the market capitalisation of Alpa Laboratories?
Ans: Alpa Laboratories has a market capitalisation of Rs 121.7619522 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Alpa Laboratories?
Ans: The PE ratio of Alpa Laboratories is 27.85023340873 and the P/B ratio of Alpa Laboratories is 0.616145634809939, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Alpa Laboratories share?
Ans: The 52-week high share price of Alpa Laboratories is Rs 93.85, and the 52-week low share price of Alpa Laboratories is Rs 46.1.

Q5. Does Alpa Laboratories pay dividends?
Ans: Currently, Alpa Laboratories does not pay dividends. Dividend yield of Alpa Laboratories is around 0%.

Q6. What are the face value and book value of Alpa Laboratories shares?
Ans: The face value of Alpa Laboratories shares is Rs 10, while the book value per share of Alpa Laboratories is around Rs 93.9226. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Alpa Laboratories?
Ans: Alpa Laboratories has a total debt of Rs 1.5081 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Alpa Laboratories?
Ans: The ROE of Alpa Laboratories is 7.8889% and ROCE of Alpa Laboratories is 8.8971%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Alpa Laboratories a good buy for the long term?
Ans: The Alpa Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Alpa Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Alpa Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Alpa Laboratories’s financials?
Ans: You can review Alpa Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Alpa Laboratories
X